Technology engagement is associated with higher perceived physical well-being in stroke patients prescribed smartwatches for atrial fibrillation detection.

Pulsewatch anxiety atrial fibrillation detection patient activation self-reported mental health self-reported physical health smartwatch

Journal

Frontiers in digital health
ISSN: 2673-253X
Titre abrégé: Front Digit Health
Pays: Switzerland
ID NLM: 101771889

Informations de publication

Date de publication:
2023
Historique:
received: 21 06 2023
accepted: 20 11 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: epublish

Résumé

Increasing ownership of smartphones among Americans provides an opportunity to use these technologies to manage medical conditions. We examine the influence of baseline smartwatch ownership on changes in self-reported anxiety, patient engagement, and health-related quality of life when prescribed smartwatch for AF detection. We performed a Ninety-six participants, primarily White with high income and tertiary education, were randomized to receive a study smartwatch-smartphone dyad. Twenty-four (25%) participants previously owned a smartwatch. Compared to those who did not previously own a smartwatch, smartwatch owners reported significant greater increase in their self-reported physical health ( Participants who own a smartwatch at baseline reported a greater positive change in self-reported physical health, but not in anxiety, patient activation, or self-reported mental health over the study period.

Sections du résumé

Background UNASSIGNED
Increasing ownership of smartphones among Americans provides an opportunity to use these technologies to manage medical conditions. We examine the influence of baseline smartwatch ownership on changes in self-reported anxiety, patient engagement, and health-related quality of life when prescribed smartwatch for AF detection.
Method UNASSIGNED
We performed a
Results UNASSIGNED
Ninety-six participants, primarily White with high income and tertiary education, were randomized to receive a study smartwatch-smartphone dyad. Twenty-four (25%) participants previously owned a smartwatch. Compared to those who did not previously own a smartwatch, smartwatch owners reported significant greater increase in their self-reported physical health (
Conclusions UNASSIGNED
Participants who own a smartwatch at baseline reported a greater positive change in self-reported physical health, but not in anxiety, patient activation, or self-reported mental health over the study period.

Identifiants

pubmed: 38125757
doi: 10.3389/fdgth.2023.1243959
pmc: PMC10731012
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1243959

Informations de copyright

© 2023 Mensah Otabil, Dai, Anzenberg, Filippaios, Ding, Mehawej, Mathew, Lessard, Wang, Noorishirazi, Hamel, Paul, DiMezza, Han, Mohagheghian, Soni, Lin, Barton, Saczynski, Chon, Tran and McManus.

Déclaration de conflit d'intérêts

DM reports receiving honorary fees, speaking/consulting fees, or research grants from FLEXcon, Heart Rhythm Society, Rose Consulting, Bristol-Myers Squibb, Pfizer, Boston Biomedical Associates, Avania, VentureWell, Samsung, Phillips, CareEvolution, Boehringer-Ingelheim, Biotronik, Otsuka Pharmaceuticals, and Sanofi; he also declares financial support for serving on the Steering Committee for the GUARD-AF study (ClinicalTrials.gov identifier NCT04126486) and Advisory Committee for the Fitbit Heart Study (ClinicalTrials.gov identifier NCT04176926). He reports non-financial research support from Apple Computer and Fitbit. The other authors have no competing interests. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Edith Mensah Otabil (E)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Qiying Dai (Q)

Division of Cardiovascular Medicine, Department of Medicine, Saint Vincent Hospital, Worcester, MA, United States.

Paula Anzenberg (P)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Andreas Filippaios (A)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Eric Ding (E)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Jordy Mehawej (J)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Joanne E Mathew (JE)

Department of Internal Medicine, Central Michigan University, Mount Pleasant, MI, United States.

Darleen Lessard (D)

Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Ziyue Wang (Z)

Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Kamran Noorishirazi (K)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Alexander Hamel (A)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Tenes Paul (T)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Danielle DiMezza (D)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Dong Han (D)

Department of Biomedical Engineering, University of Connecticut, Storrs, CT, United States.

Fahimeh Mohagheghian (F)

Department of Biomedical Engineering, University of Connecticut, Storrs, CT, United States.

Apurv Soni (A)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Honghuang Lin (H)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Bruce Barton (B)

Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Jane Saczynski (J)

Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Northeastern University, Boston, MA, United States.

Ki H Chon (KH)

Department of Biomedical Engineering, University of Connecticut, Storrs, CT, United States.

Khanh-Van Tran (KV)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

David D McManus (DD)

Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, United States.

Classifications MeSH